API 0.74% $1.35 australian pharmaceutical industries limited

may reach the 3.50 target, page-4

  1. 1,745 Posts.
    Regarding a takeover offer.

    The key figure to look at is the cash flow. The last annual report showed 57 cents per share. That means the current SP is a ratio of approximately 5/1.

    If we put a value of around 8/1 on the company then we could be looking at a value of over $4. I think that $3.50 is a fair price that leaves plenty of cash flow.



 
watchlist Created with Sketch. Add API (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.